Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil

Journal of Medical Virology

Volumn 84, Issue 7, 2012, Pages 1143-1150

  da Silva Barros, Narriman Kennia ^a   Costa, Maria Cecília ^b   Alves, Rosane Ribeiro Figueiredo ^a,c   Villa, Luísa Lina ^b   Derchain, Sophie Françoise Mauricette ^d   Zeferino, Luiz Carlos ^d   dos Santos Carneiro, Megmar Aparecida ^a   Rabelo Santos, Silvia Helena ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c Santa Casa Hospital   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; Cervical smear; PCR; Serology

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COLPOSCOPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA DETERMINATION; FEMALE; GENOTYPING TECHNIQUE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BIOPSY; BRAZIL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COLPOSCOPY; COMORBIDITY; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; IMMUNOGLOBULIN G; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGIC STUDIES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84860997698     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23312     Document Type: Article

References (34)

1. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Närvänen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. 2001. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. J Am Med Assoc 285: 47-51.
2. Calil LN, Igansi LN, Meurer L, Edelweiss MIA, Bozzetti MC. 2011. Chlamydia trachomatis and human papillomavirus coinfection: Association with p16NK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions. Braz J Infect Dis 15: 126-131.
3. Castellsague X, Munoz N. 2003. Chapter 3: Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31: 20-28.
4. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J, Schiffman M. 2001. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10: 1021-1027.
5. Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. 2006. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 24: S3/26-34.
6. Cottier O, Sahli R, Mihaescu A, De Grandi P, Boulvain M, Gerber S. 2009. Clinical follow-up of women infected with human papillomavirus-16, either alone or with other human papillomavirus types: Identification of different risk groups. Am J Obstet Gynecol 200: 286.e1-6.
7. De Paula FDF, Fernandes AP, do Carmo BB, Vieira DCD, Dutra MS, Santos CGM, Souza MCM, Andrade TCA, Vago AR, Fernandes PA. 2007. Molecular detection of Chlamydia trachomatis and HPV infections in cervical samples with normal and abnormal cytopathological findings. Diagn Cytopathol 35: 198-202.
8. Finan RR, Tamim H, Almawi WY. 2002. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet 266: 168-171.
9. Fischer N. 2002. Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynaecol Oncol 23: 247-250.
10. Gargiulo F, De Francesco MA, Schreiber C, Ciravolo G, Salinaro F, Valloncini B, Manca N. 2007. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 125: 176-182.
11. Golijow CD, Abba MC, Mourón SA, Laguens RM, Dulout FN, Smith JS. 2005. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 96: 181-186.
12. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. 1998. Genotyping of 27 human papillomavirus by using L1 consensus PCR products by a single-hybridization reverse line blot detection method. J Clin Microbiol 36: 3020-3027.
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361.
14. Hernandez-Suarez G, Ortiz N, Gonzalez M, Muñoz N. 2010. Short-term risk of cervical intraepithelial neoplasia grades 2 and 3 for women with normal cytology and human papillomavirus infection. Salud Publica Mex 52: 486-492.
15. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL, Subbaramaiah K, Dannenberg AJ. 2001. Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 7: 429-434.
16. Luostarinen T, Lehtinen M, Bjørge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T. 2004. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. Eur J Cancer 40: 1058-1065.
17. Madeleine MM, Anttila T, Schwartz SM, Saikku P, Leinonen M, Carter JJ, Wurscher M, Johnson LG, Galloway DA, Daling JR. 2007. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120: 650-655.
18. Matsumoto K, Yasugi T, Oki A, Hoshiai H, Taketani Y, Kawana T, Yoshikawa H. 2003. Are smoking and chlamydial infection risk factors for CIN? Different results after adjustment for HPV DNA and antibodies. Br J Cancer 89: 831-833.
19. Naucler P, Chen HC, Persson K, You SL, Hsieh CY, Sun CA, Dillner J, Chen C-J. 2007. Seroprevalence of human papillomaviruses and Chlamydia trachomatis and cervical cancer risk: Nested case-control study. J Gen Virol 88: 814-822.
20. Paba P, Bonifacio D, Di Bonito L, Ombres D, Favalli C, Syrjänen K, Ciotti M. 2007. Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways. Intervirology 51: 230-234.
21. Reesink-Peters N, Ossewaarde JM, Van Der Zee AG, Quint WG, Burger MP, Adriaanse AH. 2001. No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia. Sex Transm Infect 77: 101-102.
22. Ribeiro AA, Alves RRF, Costa MC, Villa LL, Zeferino LC, Derchain SFM, Carneiro MAS, Rabelo-Santos SH. 2011. Association between HPV types and species groups and cervical neoplasia from a high-risk area for Cervical Cancer, Goiânia, Brazil. Int J Gynecol Pathol 30: 288-294.
23. Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR. 2009. Human papillomavirus and cervical neoplasia. Cad Saude Publica 25: 953-964.
24. Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD. 2010. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 102: 1794-1804.
25. Samoff E, Koumans EH, Markowitz LE, Sternberg M, Sawyer MK, Swan D, Papp JR, Black CM, Unger ER. 2005. Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol 162: 668-675.
26. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ, editors. 1994. Histological typing of female genital tract tumors. In: World Health Organization. International histological classification of tumors. 2nd edition. Berlin: Springer-Verlag, Inc. pp 36-49.
27. Simonetti AC, Melo JH, de Souza PR, Bruneska D, de Lima Filho JL. 2009. Immunological's host profile for HPV and Chlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 11: 435-442.
28. Smith JS, Muñoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JMM, Peeling RW. 2002. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 185: 324-331.
29. Smith JS, Bosetti C, Muñoz N, Herrero R, Bosch FX, Eluf-Neto J, Meijer CJ, Van Den Brule AJ, Franceschi S, Peeling RW. 2004. IARC multicentric case-control study. Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer 111: 431-439.
30. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. 2006. HPV-mediated cervical carcinogenesis: Concepts and clinical implications. J Pathol 208: 152-164.
31. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. 2005. HPV-mediated transformation of the anogenital tract. J Clin Virol 32: S25-S33.
32. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY. 2002. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis 43: 277-281.
33. Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J, Nicosia R, Chiarini F, Antonelli G, Degener AM. 2009. Human papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis 9: 1-7.
34. Wheeler CM, Hunt WC, Schiffman M, Castle PE. 2006. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 194: 1291-1299.